| mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0018 |
1 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.0013 |
1 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0015 |
1 |
| mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.0012 |
1 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.0017 |
1 |
| mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
-0.0013 |
1 |
| mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0012 |
1 |
| mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
0.0012 |
1 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00095 |
1 |
| mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.0016 |
1 |